Table 3.
Antibiotics used in bioactive coatings and their antimicrobial activities.
| Antibiotic | Material | Antimicrobial Activity | Pathogen | References |
|---|---|---|---|---|
| Cefaclor (CEC) | Gold (Au) nanoparticles, cefaclor | Growth inhibition | Staphylococcus aureus, Escherichia coli | [32] |
| Cefalotin (CET) | CET, apatite | Growth inhibition | Streptococcus mutans | [51] |
| Tobramycin (TOB) | TOB, octacalcium phosphate layer | Growth inhibition | Pseudomonas aeruginosa | [52] |
| Vancomycin (VAN) | VAN, chitosan | Growth inhibition | S. aureus | [49] |
| VAN, polymer films | Growth inhibition | S. aureus | [50] | |
| Gentamicin (GEN) | GEN, poly(d,l-lactide) coating | Growth inhibition | S. aureus | [53] |
| Tetracycline (TET) | 20.0% TET, chitosan coating | 94–99% inhibition | Staphylococcus epidermidis, Aggregatibacter actinomycetemcomitans | [45] |
| Nystatin (NYT) | 1.0% NYT, polymer coating | 74–75% inhibition | Candida albicans biofilm | [46] |
| Amphotericin B (AMB) | 0.1% AMB, polymer coating | 49–55% inhibition | C. albicans biofilm | [46] |